A REVIEW OF THE ORAL SEMAGLUTIDE IN ADULTS WITH OVERWEIGHT OR OBESITY (OASIS) TRIALS EVALUATING ORAL SEMAGLUTIDE (WEGOVY) FOR CHRONIC WEIGHT MANAGEMENT IN ADULTS WITH OVERWEIGHT OR OBESITY

Descargar Publicación
The Obesity–OSA–Arrhythmia Axis: Pathophysiological Mechanisms and Translational Therapeutic Targets Una molécula, dos efectos: Un nuevo concepto farmacológico para tratar la obesidad y la diabetes tipo 2